Phase II Trial of Angiotensin-(1-7) for the Treatment of Patients with Metastatic Sarcoma.

Savage, Paul D; Lovato, James; Brosnihan, K Bridget; Miller, Antonius A; Petty, W Jeffrey

Savage, Paul D; Lovato, James; Brosnihan, K Bridget; Miller, Antonius A; Petty, W Jeffrey.

Afiliação

Savage PD; Department of Medicine, Section of Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA; Comprehensive Cancer Center of Wake Forest University, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Lovato J; Comprehensive Cancer Center of Wake Forest University, Wake Forest School of Medicine, Winston-Salem, NC, USA; Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Brosnihan KB; Department of Surgical Sciences, Center for Hypertension and Vascular Research, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Miller AA; Department of Medicine, Section of Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA; Comprehensive Cancer Center of Wake Forest University, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Petty WJ; Department of Medicine, Section of Hematology and Oncology, Wake Forest School of Medicine, Winston-Salem, NC, USA; Comprehensive Cancer Center of Wake Forest University, Wake Forest School of Medicine, Winston-Salem, NC, USA; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Sal

Sarcoma ; 2016: 4592768, 2016.

Article em En | MEDLINE | ID: mdl-27895527

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Sarcoma Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Egito

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google